Endometrial cancer risk is rising, especially among premenopausal women, with diet and lifestyle factors playing a central ...

GlaxoSmithKline Pharmaceuticals has launched Jemperli and Zejula in India, pioneering precision therapies for gynaecological ...

Jemperli is the first and only approved programmed death receptor-1 (PD-1) immunotherapy for the second-line treatment of ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast cancers are treated in the future ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

GlaxoSmithKline (GSK) on Monday announced its foray into the Indian oncology market with the launch of two precision ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

Loni Anderson's cause of death was metastatic uterine leiomyosarcoma, a rare and aggressive form of cancer. She passed away ...

GlaxoSmithKline Pharmaceuticals said it is bringing in Jemperli and Zejula to India, marking its re-entry into the cancer ...

Studies show that people receiving tamoxifen, a highly effective and commonly used therapy to treat breast cancer, face a 2- ...

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...